149 related articles for article (PubMed ID: 6857302)
1. Effect of erythromycin stearate on serum theophylline concentration in patients with chronic obstructive lung disease.
Stults BM; Felice-Johnson J; Higbee MD; Hardigan K
South Med J; 1983 Jun; 76(6):714-8. PubMed ID: 6857302
[TBL] [Abstract][Full Text] [Related]
2. Steady-state pharmacokinetics of theophylline in COPD patients treated with dirithromycin.
Bachmann K; Jauregui L; Sides G; Sullivan TJ
J Clin Pharmacol; 1993 Sep; 33(9):861-5. PubMed ID: 8227485
[TBL] [Abstract][Full Text] [Related]
3. Overnight theophylline concentrations and effects on sleep and lung function in chronic obstructive pulmonary disease.
Martin RJ; Pak J
Am Rev Respir Dis; 1992 Mar; 145(3):540-4. PubMed ID: 1546832
[TBL] [Abstract][Full Text] [Related]
4. The effect of erythromycin on theophylline pharmacokinetics at steady state.
Maddux MS; Leeds NH; Organek HW; Hasegawa GR; Bauman JL
Chest; 1982 May; 81(5):563-5. PubMed ID: 7042226
[TBL] [Abstract][Full Text] [Related]
5. Prediction of maintenance oral theophylline dosage using single oral doses in patients with obstructive airways disease.
Taylor DR; Kinney CD; McDevitt DG
Br J Clin Pharmacol; 1983 Nov; 16(5):511-6. PubMed ID: 6639837
[TBL] [Abstract][Full Text] [Related]
6. Changes in the steady-state pharmacokinetics of theophylline during treatment with dirithromycin.
Bachmann K; Nunlee M; Martin M; Sullivan T; Jauregui L; DeSante K; Sides GD
J Clin Pharmacol; 1990 Nov; 30(11):1001-5. PubMed ID: 2243147
[TBL] [Abstract][Full Text] [Related]
7. Decrease in theophylline clearance after the administration of erythromycin to a patient with obstructive lung disease.
Green JA; Clementi WA
Drug Intell Clin Pharm; 1983 May; 17(5):370-2. PubMed ID: 6861626
[TBL] [Abstract][Full Text] [Related]
8. Predictability and intraindividual variability of serum theophylline concentrations in patients with obstructive lung disease: 12-h versus 24-h dosing.
Schmidlin O; Vozeh S; Keller B; Perruchoud A; Follath F
Eur J Clin Pharmacol; 1990; 39(3):253-6. PubMed ID: 2257861
[TBL] [Abstract][Full Text] [Related]
9. Mild theophylline-related adverse reactions and serum theophylline concentration.
Barr JT; Schumacher GE; Luks DB; Karpel J
Am J Hosp Pharm; 1994 Nov; 51(21):2688-92. PubMed ID: 7856581
[TBL] [Abstract][Full Text] [Related]
10. [A single dose of theophylline in the evening in chronic obstructive airway disease. Serum concentration and lung function parameter].
Kaik G
Fortschr Med; 1984 Nov; 102(43):1120-2. PubMed ID: 6510864
[TBL] [Abstract][Full Text] [Related]
11. Theophylline kinetics and ventilatory flow in bronchial asthma and chronic airflow obstruction: influence of erythromycin.
Richer C; Mathieu M; Bah H; Thuillez C; Duroux P; Giudicelli JF
Clin Pharmacol Ther; 1982 May; 31(5):579-86. PubMed ID: 7075107
[TBL] [Abstract][Full Text] [Related]
12. Use of serum theophylline level as a guide to optimum therapy in patients with chronic obstructive lung disease.
Ashutosh K; Bajaj R; Cho CD; Sangani G
J Clin Pharmacol; 1990 Apr; 30(4):324-9. PubMed ID: 2160479
[TBL] [Abstract][Full Text] [Related]
13. The effect of erythromycin on theophylline pharmacokinetics in chronic bronchitis.
Reisz G; Pingleton SK; Melethil S; Ryan PB
Am Rev Respir Dis; 1983 May; 127(5):581-4. PubMed ID: 6846940
[TBL] [Abstract][Full Text] [Related]
14. [Effects of theophylline on lung function and sleep in patients with severe chronic obstructive pulmonary disease].
Li Y; Liu Y
Zhonghua Jie He He Hu Xi Za Zhi; 1997 Oct; 20(5):294-8. PubMed ID: 10374456
[TBL] [Abstract][Full Text] [Related]
15. [Therapy of obstructive respiratory tract diseases with pure theophylline retard].
Arens PJ
Med Klin Prax; 1982 Aug; 77(18):48-53, 67. PubMed ID: 6752679
[TBL] [Abstract][Full Text] [Related]
16. Acute bronchodilating effects of ipratropium bromide and theophylline in chronic obstructive pulmonary disease.
Bleecker ER; Britt EJ
Am J Med; 1991 Oct; 91(4A):24S-27S. PubMed ID: 1835291
[TBL] [Abstract][Full Text] [Related]
17. Effect of theophylline in chronic obstructive lung disease.
Umut S; Gemicioğlu B; Yildirim N; Barlas A; Ozüner Z
Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):149-52. PubMed ID: 1592541
[TBL] [Abstract][Full Text] [Related]
18. Intersubject variability in plasma theophylline levels after oral and intravenous administration in Jordanian patients with chronic obstructive pulmonary disease.
Samara N; Sliman N; Sai'd S; Awidi A; Al-Turk W; Othman S; Khalaf R; Shaheen O
Ther Drug Monit; 1988; 10(2):144-6. PubMed ID: 3381229
[TBL] [Abstract][Full Text] [Related]
19. Plasma theophylline concentrations in patients with chronic obstructive airways disease after administration of a new sustained release theophylline formulation.
Taylor DR; Kinney CD; McDevitt DG
Br J Clin Pharmacol; 1982 Apr; 13(4):569-71. PubMed ID: 7066172
[No Abstract] [Full Text] [Related]
20. Effect of erythromycin on theophylline clearance in asthmatic children.
LaForce CF; Miller MF; Chai H
J Pediatr; 1981 Jul; 99(1):153-6. PubMed ID: 7252653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
